XTransfer, the world's leading B2B cross-border trade payment platform, made its debut at Money20/20 USA 2026 in Las Vegas as ...

AiMOGA Robotics has officially launched Mobo, its first consumer-grade humanoid family companion robot, marking a new chapter in intelligent living for Malaysian households and enterprises. Unveiled ...

The 2026 CSCCP-ASCCP Colposcopy Training Course, held in Wuhan from October 21 to 23, concluded successfully. Jointly ...

Your cervical cancer screening results have arrived. The words "requires detailed examination" and the unfamiliar acronym "ASC-US" appear. You start to search for it, but your hand stops.Is it ...

When I first received my laboratory report, seeing a cyclic citrullinated peptide strong positive result was an overwhelming experience. As someone deeply interested in personal health optimization ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Over 13 million pregnancy tests have been recalled around the world, including in the U.S., according to a little-noticed posting on the FDA’s website. The pregnancy tests, which were distributed to ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. What happens inside your body when you suddenly stop drinking coffee?

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced positive topline results from the planned interim analysis of the ACTION-1 trial (NCT05477576) conducted by RayzeBio ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, today announced positive topline results from the Phase 2 study evaluating FB102, a ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence ...